Stefania Tommasi

Stefania Tommasi

UNVERIFIED PROFILE

Are you Stefania Tommasi?   Register this Author

Register author
Stefania Tommasi

Stefania Tommasi

Publications by authors named "Stefania Tommasi"

Are you Stefania Tommasi?   Register this Author

100Publications

1714Reads

26Profile Views

Exhaled breath condensate biomarkers for lung cancer.

J Breath Res 2019 Jul 8. Epub 2019 Jul 8.

Molecular Diagnostics and Pharmacogenetics Unit, IRCCS Istituto Tumori "Giovanni Paolo II" , v.le Orazio Flacco 65, Bari, ITALY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1088/1752-7163/ab2f9fDOI Listing
July 2019

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2019 02;566(7742):E1

Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41586-019-0883-2
Publisher Site
http://dx.doi.org/10.1038/s41586-019-0883-2DOI Listing
February 2019

Standardization of CTC AR-V7 PCR assay and evaluation of its role in castration resistant prostate cancer progression.

Prostate 2019 01 23;79(1):54-61. Epub 2018 Aug 23.

Medical Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23710DOI Listing
January 2019

Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets.

Expert Opin Ther Targets 2018 05 27;22(5):453-461. Epub 2018 Mar 27.

c Pharmacogenetics and Molecular Diagnostic Unit , Istituto Tumori "Giovanni Paolo II" , Bari , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14728222.2018.1
Publisher Site
http://dx.doi.org/10.1080/14728222.2018.1456530DOI Listing
May 2018

VEGF and TWIST1 in a 16-biomarker immunoprofile useful for prognosis of breast cancer patients.

Int J Cancer 2017 11 20;141(9):1901-1911. Epub 2017 Jul 20.

Functional Biomorphology Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.30868DOI Listing
November 2017

Angiogenesis in adenosquamous cancer of pancreas.

Oncotarget 2017 Nov 27;8(56):95773-95779. Epub 2017 Sep 27.

Molecular Genetics Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II", 70124, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.21319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707059PMC
November 2017

Adipokines in hereditary breast cancer patients and healthy relatives.

Oncotarget 2017 11 18;8(60):101255-101261. Epub 2017 Sep 18.

Molecular Genetic Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.21018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731871PMC
November 2017

Comment on 'Renewed interest in the progesterone receptor in breast cancer'.

Br J Cancer 2017 07 11;117(2):e1. Epub 2017 Apr 11.

Experimental Medical Oncology, Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Research Institute, via O Flacco 65, Bari I-70124, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.90DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520524PMC
July 2017

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.

Authors:
Julie Lecarpentier Valentina Silvestri Karoline B Kuchenbaecker Daniel Barrowdale Joe Dennis Lesley McGuffog Penny Soucy Goska Leslie Piera Rizzolo Anna Sara Navazio Virginia Valentini Veronica Zelli Andrew Lee Ali Amin Al Olama Jonathan P Tyrer Melissa Southey Esther M John Thomas A Conner David E Goldgar Saundra S Buys Ramunas Janavicius Linda Steele Yuan Chun Ding Susan L Neuhausen Thomas V O Hansen Ana Osorio Jeffrey N Weitzel Angela Toss Veronica Medici Laura Cortesi Ines Zanna Domenico Palli Paolo Radice Siranoush Manoukian Bernard Peissel Jacopo Azzollini Alessandra Viel Giulia Cini Giuseppe Damante Stefania Tommasi Paolo Peterlongo Florentia Fostira Ute Hamann D Gareth Evans Alex Henderson Carole Brewer Diana Eccles Jackie Cook Kai-Ren Ong Lisa Walker Lucy E Side Mary E Porteous Rosemarie Davidson Shirley Hodgson Debra Frost Julian Adlard Louise Izatt Ros Eeles Steve Ellis Marc Tischkowitz Andrew K Godwin Alfons Meindl Andrea Gehrig Bernd Dworniczak Christian Sutter Christoph Engel Dieter Niederacher Doris Steinemann Eric Hahnen Jan Hauke Kerstin Rhiem Karin Kast Norbert Arnold Nina Ditsch Shan Wang-Gohrke Barbara Wappenschmidt Dorothea Wand Christine Lasset Dominique Stoppa-Lyonnet Muriel Belotti Francesca Damiola Laure Barjhoux Sylvie Mazoyer Mattias Van Heetvelde Bruce Poppe Kim De Leeneer Kathleen B M Claes Miguel de la Hoya Vanesa Garcia-Barberan Trinidad Caldes Pedro Perez Segura Johanna I Kiiski Kristiina Aittomäki Sofia Khan Heli Nevanlinna Christi J van Asperen Tibor Vaszko Miklos Kasler Edith Olah Judith Balmaña Sara Gutiérrez-Enríquez Orland Diez Alex Teulé Angel Izquierdo Esther Darder Joan Brunet Jesús Del Valle Lidia Feliubadalo Miquel Angel Pujana Conxi Lazaro Adalgeir Arason Bjarni A Agnarsson Oskar Th Johannsson Rosa B Barkardottir Elisa Alducci Silvia Tognazzo Marco Montagna Manuel R Teixeira Pedro Pinto Amanda B Spurdle Helene Holland Jong Won Lee Min Hyuk Lee Jihyoun Lee Sung-Won Kim Eunyoung Kang Zisun Kim Priyanka Sharma Timothy R Rebbeck Joseph Vijai Mark Robson Anne Lincoln Jacob Musinsky Pragna Gaddam Yen Y Tan Andreas Berger Christian F Singer Jennifer T Loud Mark H Greene Anna Marie Mulligan Gord Glendon Irene L Andrulis Amanda Ewart Toland Leigha Senter Anders Bojesen Henriette Roed Nielsen Anne-Bine Skytte Lone Sunde Uffe Birk Jensen Inge Sokilde Pedersen Lotte Krogh Torben A Kruse Maria A Caligo Sook-Yee Yoon Soo-Hwang Teo Anna von Wachenfeldt Dezheng Huo Sarah M Nielsen Olufunmilayo I Olopade Katherine L Nathanson Susan M Domchek Christa Lorenchick Rachel C Jankowitz Ian Campbell Paul James Gillian Mitchell Nick Orr Sue Kyung Park Mads Thomassen Kenneth Offit Fergus J Couch Jacques Simard Douglas F Easton Georgia Chenevix-Trench Rita K Schmutzler Antonis C Antoniou Laura Ottini

J Clin Oncol 2017 Jul 27;35(20):2240-2250. Epub 2017 Apr 27.

Julie Lecarpentier, Karoline B. Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Goska Leslie, Andrew Lee, Ali Amin Al Olama, Jonathan P. Tyrer, Debra Frost, Steve Ellis, Douglas F. Easton, and Antonis C. Antoniou, University of Cambridge; Karoline B. Kuchenbaecker, The Wellcome Trust Sanger Institute, Hinxton; Marc Tischkowitz, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Cambridge; D. Gareth Evans, Manchester University, Central Manchester University Hospitals NHS Foundation Trust, Manchester; Alex Henderson, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne; Carole Brewer, Royal Devon and Exeter Hospital, Exeter; Diana Eccles, Southampton University Hospitals NHS Trust, Southampton; Jackie Cook, Sheffield Children's Hospital, Sheffield; Kai-ren Ong, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham; Lisa Walker, Churchill Hospital, Oxford; Lucy E. Side, Great Ormond Street Hospital for Children NHS Trust; Shirley Hodgson, St George's, University of London; Louise Izatt, Guy's and St Thomas' NHS Foundation Trust; Ros Eeles, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust; Nick Orr, The Institute of Cancer Research, London; Mary E. Porteous, Western General Hospital, Edinburgh; Rosemarie Davidson, South Glasgow University Hospitals, Glasgow; Julian Adlard, Chapel Allerton Hospital, Leeds, United Kingdom; Valentina Silvestri, Piera Rizzolo, Anna Sara Navazio, Virginia Valentini, Veronica Zelli, and Laura Ottini, Sapienza University of Rome, Rome; Angela Toss, Veronica Medici, and Laura Cortesi, University of Modena and Reggio Emilia, Modena; Ines Zanna and Domenico Palli, Cancer Research and Prevention Institute, Florence; Paolo Radice, Siranoush Manoukian, Bernard Peissel, and Jacopo Azzollini, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori (INT); Paolo Peterlongo, Italian Foundation for Cancer Research Institute of Molecular Oncology (IFOM), Milan; Alessandra Viel and Giulia Cini, CRO Aviano, National Cancer Institute, Aviano; Giuseppe Damante, University of Udine, Udine; Stefania Tommasi, Istituto Nazionale Tumori "Giovanni Paolo II", Bari; Elisa Alducci, Silvia Tognazzo, and Marco Montagna, Veneto Institute of Oncology IOV - IRCCS, Padua; Maria A. Caligo, University and University Hospital of Pisa, Pisa, Italy; Penny Soucy and Jacques Simard, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec; Anna Marie Mulligan and Irene L. Andrulis, University of Toronto; Gord Glendon and Irene L. Andrulis, Mount Sinai Hospital, Toronto, Ontario, Canada; Melissa Southey, Ian Campbell, Paul James, and Gillian Mitchell, University of Melbourne, Parkville, Victoria; Amanda B. Spurdle, Helene Holland, and Georgia Chenevix-Trench, QIMR Berghofer Medical Research Institute, Brisbane, Queensland; Ian Campbell, Paul James, and Gillian Mitchell, Peter MacCallum Cancer Centre, East Melbourne, New South Wales, Australia; Esther M. John, Cancer Prevention Institute of California, Fremont; Linda Steele, Yuan Chun Ding, Susan L. Neuhausen, and Jeffrey N. Weitzel, City of Hope, Duarte, CA; Thomas A. Conner and Saundra S. Buys, Huntsman Cancer Institute; David E. Goldgar, University of Utah School of Medicine, Salt Lake City, UT; Andrew K. Godwin, University of Kansas Medical Center, Kansas City; Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; Timothy R. Rebbeck, Harvard TH Chan School of Public Health and Dana Farber Cancer Institute, Boston, MA; Joseph Vijai, Mark Robson, Anne Lincoln, Jacob Musinsky, Pragna Gaddam, and Kenneth Offit, Memorial Sloan Kettering Cancer Center, New York, NY; Jennifer T. Loud and Mark H. Greene, National Cancer Institute, Bethesda, MD; Amanda Ewart Toland and Leigha Senter, The Ohio State University, Columbus, OH; Dezheng Huo, Sarah M. Nielsen, and Olufunmilayo I. Olopade, University of Chicago Medical Center, Chicago, IL; Katherine L. Nathanson and Susan M. Domchek, University of Pennsylvania, Philadelphia; Christa Lorenchick and Rachel C. Jankowitz, University of Pittsburgh Medical Center, Pittsburgh, PA; Fergus J. Couch, Mayo Clinic, Rochester, MN; Ramunas Janavicius, State Research Institute Innovative Medicine Center, Vilnius, Lithuania; Thomas V.O. Hansen, Rigshospitalet, Copenhagen University Hospital, Copenhagen; Anders Bojesen and Henriette Roed Nielsen, Vejle Hospital, Vejle; Anne-Bine Skytte, Lone Sunde, and Uffe Birk Jensen, Aarhus University Hospital, Aarhus; Inge Sokilde Pedersen, Aalborg University Hospital, Aalborg; Lotte Krogh, Torben A. Kruse, and Mads Thomassen, Odense University Hospital, Odense, Denmark; Ana Osorio, National Cancer Research Centre and Spanish Network on Rare Diseases; Miguel de la Hoya, Vanesa Garcia-Barberan, Trinidad Caldes, and Pedro Perez Segura, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid; Judith Balmaña, University Hospital, Vall d'Hebron; Sara Gutiérrez-Enríquez and Orland Diez, Vall d'Hebron Institute of Oncology; Orland Diez, University Hospital Vall d'Hebron; Alex Teulé, Jesús Del Valle, Lidia Feliubadalo, Miquel Angel Pujana, and Conxi Lazaro, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, Barcelona; Angel Izquierdo, Esther Darder, and Joan Brunet, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain; Florentia Fostira, National Centre for Scientific Research "Demokritos," Athens, Greece; Ute Hamann, German Cancer Research Center (DKFZ); Christian Sutter, University Hospital Heidelberg, Heidelberg; Alfons Meindl, Klinikumrechts der Isar, Technical University Munich; Nina Ditsch, Ludwig-Maximilian University, Munich; Andrea Gehrig, University Würzburg, Würzburg; Bernd Dworniczak, University of Münster, Münster; Christoph Engel, University of Leipzig; Dorothea Wand, University Hospital, Leipzig; Dieter Niederacher, University Hospital Düsseldorf, Heinrich-Heine University, Düsseldorf; Doris Steinemann, Hannover Medical School, Hannover; Eric Hahnen, Jan Hauke, Kerstin Rhiem, Barbara Wappenschmidt, and Rita K. Schmutzler, University Hospital Cologne, Cologne; Karin Kast, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden; Norbert Arnold, University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel, Kiel; Shan Wang-Gohrke, University Hospital Ulm, Ulm, Germany; Christine Lasset, Francesca Damiola, and Laure Barjhoux, Centre Léon Bérard; Sylvie Mazoyer, University of Lyon, Lyon; Dominique Stoppa-Lyonnet and Muriel Belotti, Institut Curie, Paris, France; Mattias Van Heetvelde, Bruce Poppe, Kim De Leeneer, and Kathleen B.M. Claes, Ghent University, Gent, Belgium; Johanna I. Kiiski, Sofia Khan, and Heli Nevanlinna, University of Helsinki; Johanna I. Kiiski, Kristiina Aittomäki, Sofia Khan, and Heli Nevanlinna, Helsinki University Hospital, Helsinki, Finland; Christi J. van Asperen, Leiden University Medical Center, Leiden, the Netherlands; Tibor Vaszko, Miklos Kasler, and Edith Olah, National Institute of Oncology, Budapest, Hungary; Adalgeir Arason, Bjarni A. Agnarsson, Oskar Th. Johannsson, and Rosa B. Barkardottir, Landspitali University Hospital and Biomedical Centre, University of Iceland, Reykjavik, Iceland; Manuel R. Teixeira and Pedro Pinto, Portuguese Oncology Institute; Manuel R. Teixeira, Porto University, Porto, Portugal; Jong Won Lee, Ulsan College of Medicine and Asan Medical Center; Min Hyuk Lee and Jihyoun Lee, Soonchunhyang University and Hospital; Sung-Won Kim and Eunyoung Kang, Daerim St Mary's Hospital; Sue Kyung Park, Seoul National University College of Medicine, Seoul; Zisun Kim, Soonchunhyang University Bucheon Hospital, Bucheon, Korea; Yen Y. Tan, Andreas Berger, and Christian F. Singer, Medical University of Vienna, Vienna, Austria; Sook-Yee Yoon and Soo-Hwang Teo, Sime Darby Medical Centre, Subang Jaya, Malaysia; and Anna von Wachenfeldt, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.4935DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501359PMC
July 2017

GATK hard filtering: tunable parameters to improve variant calling for next generation sequencing targeted gene panel data.

BMC Bioinformatics 2017 Mar 23;18(Suppl 5):119. Epub 2017 Mar 23.

IRCCS-Istituto Tumori "Giovanni Paolo II", Molecular Genetics Laboratory, viale Orazio Flacco, 65, 70124, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12859-017-1537-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374681PMC
March 2017

MicroRNA expression in BRAF-mutated and wild-type metastatic melanoma and its correlation with response duration to BRAF inhibitors.

Expert Opin Ther Targets 2015 ;19(8):1027-35

1IRCCS Istituto Tumori "Giovanni Paolo II", Molecular Genetics Laboratory , Bari , Italy +0039 0805555283 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728222.2015.1065818DOI Listing
January 2017

miR-151-5p, targeting chromatin remodeler SMARCA5, as a marker for the BRCAness phenotype.

Oncotarget 2016 Dec;7(49):80363-80372

IRCCS Istituto Tumori "Giovanni Paolo II", Molecular Genetics Laboratory, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.10345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348325PMC
December 2016

Next-generation sequencing: advances and applications in cancer diagnosis.

Onco Targets Ther 2016 2;9:7355-7365. Epub 2016 Dec 2.

Molecular Genetics Laboratory, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S99807DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144906PMC
December 2016

New insight into the role of metabolic reprogramming in melanoma cells harboring BRAF mutations.

Biochim Biophys Acta 2016 11 16;1863(11):2710-2718. Epub 2016 Aug 16.

Department of Basic Medical Sciences Neurosciences and Sense Organs, University of Bari, Bari, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbamcr.2016.08.007DOI Listing
November 2016

EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations.

Breast Cancer Res Treat 2016 11 15;160(1):181-186. Epub 2016 Sep 15.

Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3976-8DOI Listing
November 2016

BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report.

Genes Chromosomes Cancer 2016 10 4;55(10):803-13. Epub 2016 Jul 4.

Molecular Genetics Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II,", Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22383DOI Listing
October 2016

Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2016 06 2;534(7605):47-54. Epub 2016 May 2.

Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature17676DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910866PMC
June 2016

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.

Authors:
Valentina Silvestri Daniel Barrowdale Anna Marie Mulligan Susan L Neuhausen Stephen Fox Beth Y Karlan Gillian Mitchell Paul James Darcy L Thull Kristin K Zorn Natalie J Carter Katherine L Nathanson Susan M Domchek Timothy R Rebbeck Susan J Ramus Robert L Nussbaum Olufunmilayo I Olopade Johanna Rantala Sook-Yee Yoon Maria A Caligo Laura Spugnesi Anders Bojesen Inge Sokilde Pedersen Mads Thomassen Uffe Birk Jensen Amanda Ewart Toland Leigha Senter Irene L Andrulis Gord Glendon Peter J Hulick Evgeny N Imyanitov Mark H Greene Phuong L Mai Christian F Singer Christine Rappaport-Fuerhauser Gero Kramer Joseph Vijai Kenneth Offit Mark Robson Anne Lincoln Lauren Jacobs Eva Machackova Lenka Foretova Marie Navratilova Petra Vasickova Fergus J Couch Emily Hallberg Kathryn J Ruddy Priyanka Sharma Sung-Won Kim Manuel R Teixeira Pedro Pinto Marco Montagna Laura Matricardi Adalgeir Arason Oskar Th Johannsson Rosa B Barkardottir Anna Jakubowska Jan Lubinski Angel Izquierdo Miguel Angel Pujana Judith Balmaña Orland Diez Gabriella Ivady Janos Papp Edith Olah Ava Kwong Heli Nevanlinna Kristiina Aittomäki Pedro Perez Segura Trinidad Caldes Tom Van Maerken Bruce Poppe Kathleen B M Claes Claudine Isaacs Camille Elan Christine Lasset Dominique Stoppa-Lyonnet Laure Barjhoux Muriel Belotti Alfons Meindl Andrea Gehrig Christian Sutter Christoph Engel Dieter Niederacher Doris Steinemann Eric Hahnen Karin Kast Norbert Arnold Raymonda Varon-Mateeva Dorothea Wand Andrew K Godwin D Gareth Evans Debra Frost Jo Perkins Julian Adlard Louise Izatt Radka Platte Ros Eeles Steve Ellis Ute Hamann Judy Garber Florentia Fostira George Fountzilas Barbara Pasini Giuseppe Giannini Piera Rizzolo Antonio Russo Laura Cortesi Laura Papi Liliana Varesco Domenico Palli Ines Zanna Antonella Savarese Paolo Radice Siranoush Manoukian Bernard Peissel Monica Barile Bernardo Bonanni Alessandra Viel Valeria Pensotti Stefania Tommasi Paolo Peterlongo Jeffrey N Weitzel Ana Osorio Javier Benitez Lesley McGuffog Sue Healey Anne-Marie Gerdes Bent Ejlertsen Thomas V O Hansen Linda Steele Yuan Chun Ding Nadine Tung Ramunas Janavicius David E Goldgar Saundra S Buys Mary B Daly Anita Bane Mary Beth Terry Esther M John Melissa Southey Douglas F Easton Georgia Chenevix-Trench Antonis C Antoniou Laura Ottini

Breast Cancer Res 2016 Feb 9;18(1):15. Epub 2016 Feb 9.

Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena, 324, 00161, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-016-0671-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746828PMC
February 2016

FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.

Authors:
Paolo Peterlongo Irene Catucci Mara Colombo Laura Caleca Eliseos Mucaki Massimo Bogliolo Maria Marin Francesca Damiola Loris Bernard Valeria Pensotti Sara Volorio Valentina Dall'Olio Alfons Meindl Claus Bartram Christian Sutter Harald Surowy Valérie Sornin Marie-Gabrielle Dondon Séverine Eon-Marchais Dominique Stoppa-Lyonnet Nadine Andrieu Olga M Sinilnikova Gillian Mitchell Paul A James Ella Thompson Marina Marchetti Cristina Verzeroli Carmen Tartari Gabriele Lorenzo Capone Anna Laura Putignano Maurizio Genuardi Veronica Medici Isabella Marchi Massimo Federico Silvia Tognazzo Laura Matricardi Simona Agata Riccardo Dolcetti Lara Della Puppa Giulia Cini Viviana Gismondi Valeria Viassolo Chiara Perfumo Maria Antonietta Mencarelli Margherita Baldassarri Bernard Peissel Gaia Roversi Valentina Silvestri Piera Rizzolo Francesca Spina Caterina Vivanet Maria Grazia Tibiletti Maria Adelaide Caligo Gaetana Gambino Stefania Tommasi Brunella Pilato Carlo Tondini Chiara Corna Bernardo Bonanni Monica Barile Ana Osorio Javier Benitez Luisa Balestrino Laura Ottini Siranoush Manoukian Marco A Pierotti Alessandra Renieri Liliana Varesco Fergus J Couch Xianshu Wang Peter Devilee Florentine S Hilbers Christi J van Asperen Alessandra Viel Marco Montagna Laura Cortesi Orland Diez Judith Balmaña Jan Hauke Rita K Schmutzler Laura Papi Miguel Angel Pujana Conxi Lázaro Anna Falanga Kenneth Offit Joseph Vijai Ian Campbell Barbara Burwinkel Anders Kvist Hans Ehrencrona Sylvie Mazoyer Sara Pizzamiglio Paolo Verderio Jordi Surralles Peter K Rogan Paolo Radice

Hum Mol Genet 2015 Sep 30;24(18):5345-55. Epub 2015 Jun 30.

IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddv251DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550823PMC
September 2015

Immunoprofile from tissue microarrays to stratify familial breast cancer patients.

Oncotarget 2015 Sep;6(29):27865-79

Functional Biomorphology Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.4720DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695031PMC
September 2015

Metastatic melanoma cells with BRAF G469A mutation: nab-paclitaxel better than vemurafenib?

Cancer Chemother Pharmacol 2015 Aug 13;76(2):433-8. Epub 2015 Jun 13.

Clinical and Preclinical Pharmacology Lab, National Cancer Research Centre Istituto Tumori Giovanni Paolo II, Viale O. Flacco, 65, 70124, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2796-6DOI Listing
August 2015

The value of new high-throughput technologies for diagnosis and prognosis in solid tumors.

Cancer Biomark 2014 ;14(2-3):103-17

National Cancer Research Centre "Giovanni Paolo II", Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/CBM-130328DOI Listing
July 2015

Combined microRNA and ER expression: a new classifier for familial and sporadic breast cancer patients.

J Transl Med 2014 Nov 19;12:319. Epub 2014 Nov 19.

Molecular Genetics Laboratory, IRCCS, Istituto Tumori "Giovanni Paolo II", v,le Orazio Flacco 65, Bari, 70124, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-014-0319-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239401PMC
November 2014

Mitochondrial DNA variants and risk of familial breast cancer: an exploratory study.

Int J Oncol 2014 May 5;44(5):1691-8. Epub 2014 Mar 5.

Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari 'Aldo Moro', Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2014.2324DOI Listing
May 2014

BRCA1/2 and clinical outcome in a monoinstitutional cohort of women with hereditary breast cancer.

Oncol Rep 2014 Jan 22;31(1):365-9. Epub 2013 Oct 22.

National Cancer Research Centre 'Giovanni Paolo II', I-70124 Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2013.2802DOI Listing
January 2014

Genetic risk transmission in a family affected by familial breast cancer.

J Hum Genet 2014 Jan 24;59(1):51-3. Epub 2013 Oct 24.

IRCCS National Cancer Centre "Giovanni Paolo II", Molecular Genetics Laboratory, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jhg.2013.109DOI Listing
January 2014

Molecular profiling of thin-prep FNA samples in assisting clinical management of non-small-cell lung cancer.

Mol Biotechnol 2013 Jul;54(3):913-9

National Cancer Research Centre, Istituto Tumori "Giovanni Paolo II", v. Orazio Flacco 65, 70124 Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12033-012-9640-6DOI Listing
July 2013

Different methylation and microRNA expression pattern in male and female familial breast cancer.

J Cell Physiol 2013 Jun;228(6):1264-9

Molecular Genetics Laboratory - NCRC Giovanni Paolo II, Bari, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jcp.24281
Publisher Site
http://dx.doi.org/10.1002/jcp.24281DOI Listing
June 2013

Mitochondria and familial predisposition to breast cancer.

Curr Genomics 2013 May;14(3):195-203

National Cancer Research Centre, Istituto Tumori "Giovanni Paolo II", Bari-Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389202911314030005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664469PMC
May 2013

HOX gene methylation status analysis in patients with hereditary breast cancer.

J Hum Genet 2013 Jan 11;58(1):51-3. Epub 2012 Oct 11.

National Cancer Research Centre, Istituto Tumori Giovanni Paolo II, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jhg.2012.118DOI Listing
January 2013

DHPLC/SURVEYOR nuclease: a sensitive, rapid and affordable method to analyze BRCA1 and BRCA2 mutations in breast cancer families.

Mol Biotechnol 2012 Sep;52(1):8-15

National Cancer Centre Giovanni Paolo II, Molecular Genetics Laboratory, v. Orazio Flacco 65, 70124 Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12033-011-9468-5DOI Listing
September 2012

Comparison of data-merging methods with SVM attribute selection and classification in breast cancer gene expression.

BMC Bioinformatics 2012 May 8;13 Suppl 7:S9. Epub 2012 May 8.

Department of Electrical and Electronics, Polytechnic of Bari, Via E, Orabona, 4, 70125 Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2105-13-S7-S9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348047PMC
May 2012

Human epidermal growth factor receptor 2, Na+/H+ exchanger regulatory factor 1, and breast cancer susceptibility gene-1 as new biomarkers for familial breast cancers.

Hum Pathol 2011 Nov 14;42(11):1589-95. Epub 2011 Apr 14.

Clinical Experimental Oncology Laboratory, National Cancer Centre, Viale Orazio Flacco, 65-70124 Bari, Italy.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S004681771100040
Publisher Site
http://dx.doi.org/10.1016/j.humpath.2011.01.010DOI Listing
November 2011

MC70 potentiates doxorubicin efficacy in colon and breast cancer in vitro treatment.

Eur J Pharmacol 2011 Nov 5;670(1):74-84. Epub 2011 Sep 5.

Clinical Experimental Oncology Laboratory, National Cancer Institute Giovanni Paolo II, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2011.08.025DOI Listing
November 2011

Gene copy number variation in male breast cancer by aCGH.

Cell Oncol (Dordr) 2011 Oct 6;34(5):467-73. Epub 2011 May 6.

Clinical Experimental Oncology Laboratory, National Cancer Centre of Bari, viale Orazio Flacco 65, 70124 Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13402-011-0041-9DOI Listing
October 2011

Oncosuppressor methylation: a possible key role in colon metastatic progression.

J Cell Physiol 2011 Jul;226(7):1934-9

Clinical Experimental Oncology Laboratory, National Cancer Centre Giovanni Paolo II, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.22524DOI Listing
July 2011

Determining and interpreting new predictive rules for breast cancer familial inheritance.

OMICS 2011 Mar 14;15(3):125-31. Epub 2011 Feb 14.

Clinical Experimental Oncology Laboratory, National Cancer Centre of Bari, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/omi.2010.0080DOI Listing
March 2011

Mutations and polymorphic BRCA variants transmission in breast cancer familial members.

Breast Cancer Res Treat 2011 Feb 30;125(3):651-7. Epub 2010 Mar 30.

Clinical Experimental Oncology Laboratory, National Cancer Institute, Giovanni Paolo II- v., Hahneman 10, 70126, Bari, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-010-0861-8
Publisher Site
http://dx.doi.org/10.1007/s10549-010-0861-8DOI Listing
February 2011

Anti-EGFR monoclonal antibody in cancer treatment: in vitro and in vivo evidence

Front Biosci (Landmark Ed) 2011 01 1;16:1973-85. Epub 2011 Jan 1.

Clinical Experimental Oncology Laboratory, National Cancer Institute Giovanni Paolo II, Via Hahnemann 10, 70126 Bari, Italy.

View Article

Download full-text PDF

Source
January 2011

Targeting EGFR in bilio-pancreatic and liver carcinoma.

Front Biosci (Schol Ed) 2011 Jan 1;3:16-22. Epub 2011 Jan 1.

Medical Oncology, University Campus Bio-Medico, Rome.

View Article

Download full-text PDF

Source
January 2011

Maternal and paternal lineage double heterozygosity alteration in familial breast cancer: a first case report.

Breast Cancer Res Treat 2010 Dec 21;124(3):875-8. Epub 2010 Aug 21.

Clinical Experimental Oncology Laboratory, National Cancer Centre, Giovanni Paolo II- v. Hahnemann 10, 70126, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-1125-3DOI Listing
December 2010

Histological features of extratumoral breast lesions as a predictive factor of familial breast cancer.

Oncol Rep 2010 Jun;23(6):1641-5

Clinical Experimental Oncology Laboratory, National Cancer Institute, 70126 Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or_00000806DOI Listing
June 2010

The dark side of the moon: the PI3K/PTEN/AKT pathway in colorectal carcinoma.

Oncology 2009 2;77 Suppl 1:69-74. Epub 2010 Feb 2.

Medical and Experimental Oncology Unit, Cancer Institute Giovanni Paolo II, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000258498DOI Listing
March 2010

Developing optimal input design strategies in cancer systems biology with applications to microfluidic device engineering.

BMC Bioinformatics 2009 Oct 15;10 Suppl 12:S4. Epub 2009 Oct 15.

Department of Electrical Engineering and Electronics, Technical University of Bari, Via E. Orabona 4, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2105-10-S12-S4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762069PMC
October 2009

Circulating hTERT DNA in early breast cancer.

Anticancer Res 2009 Jul;29(7):2845-9

Department of Experimental Oncology, IRCCS Istituto Tumori Giovanni Paolo II, Bari, 70126 Bari, Italy.

View Article

Download full-text PDF

Source
July 2009

KRAS mutations and sensitivity to anti-EGFR monoclonal antibodies in metastatic colorectal carcinoma: an open issue.

Expert Opin Biol Ther 2009 May;9(5):565-77

Scientific Institute for Research and Treatment of Cancer Giovanni Paolo II, Medical and Experimental Oncology Unit, Bari, Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1517/147125909028703
Publisher Site
http://dx.doi.org/10.1517/14712590902870394 DOI Listing
May 2009

SELDI-TOF serum proteomics and breast cancer: which perspective?

Expert Rev Proteomics 2008 Dec;5(6):779-85

Chemical-Clinical Microbiology and Immunology Laboratory Unit, 'Giovanni Paolo II', National Cancer Institute, Via Samuel F. Hahnemann 10, 70126 Bari, Italy.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14789450.5.6.779
Publisher Site
http://dx.doi.org/10.1586/14789450.5.6.779DOI Listing
December 2008

"Sequencing-grade" screening for BRCA1 variants by oligo-arrays.

J Transl Med 2008 Oct 30;6:64. Epub 2008 Oct 30.

Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://translational-medicine.biomedcentral.com/articles/10.
Publisher Site
http://dx.doi.org/10.1186/1479-5876-6-64DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583995PMC
October 2008

Molecular and in silico analysis of BRCA1 and BRCA2 variants.

Mutat Res 2008 Sep 18;644(1-2):64-70. Epub 2008 Jul 18.

National Cancer Institute "Giovanni Paolo II"- v. Hahnemann 10, 70126 Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mrfmmm.2008.07.005DOI Listing
September 2008

PAI-1, t-PA and circulating hTERT DNA as related to virus infection in liver carcinogenesis.

Anticancer Res 2008 Jan-Feb;28(1A):223-8

Chemical-Clinical Microbiology and Immunology Laboratory Unit, Giovanni Paolo II, National Cancer Institute, Bari, Italy.

View Article

Download full-text PDF

Source
April 2008

Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancers.

Cancer Genet Cytogenet 2008 Apr;182(2):75-83

Clinical Experimental Oncology Laboratory, National Cancer Institute, Hahneman n. 10, 70126, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2008.01.002DOI Listing
April 2008

3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.

Am J Respir Crit Care Med 2008 Feb 25;177(3):337-41. Epub 2007 Oct 25.

Institute of Respiratory Disease, University of Foggia, Foggia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.200707-1136OCDOI Listing
February 2008

Impact of sample preparation in peptide/protein profiling in human serum by MALDI-TOF mass spectrometry.

J Pharm Biomed Anal 2008 Jan 16;46(1):157-64. Epub 2007 Oct 16.

Università degli Studi di Bari, Centro Interdipartimentale di Ricerca S.M.A.R.T., Dipartimento di Chimica, Via Orabona 4, 70126-Bari, Italy.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S073170850700599
Publisher Site
http://dx.doi.org/10.1016/j.jpba.2007.10.015DOI Listing
January 2008

Phosphatidylinositol 3-kinase in breast cancer: where from here?

Clin Cancer Res 2007 Oct;13(20):5988-90

Clinical Experimental Oncology Laboratory, National Cancer Institute, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-1106DOI Listing
October 2007